Current research highlights the significant role of the NLRP3 inflammasome pathway in the pathogenesis of atherosclerotic conditions such as myocardial infarction and ischemic cerebral infarction, positioning it as a potential therapeutic target in atherosclerosis management. The gene discussed is NLRP3; the disease is myocardial infarction.